Vivian Andrew Fonseca
Vivian Andrew Fonseca publishes mostly in Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Diabetes, Cardiovascular Risks, and Lipoproteins.
- World rank
- #141,024 of 7,710,434 ranked researchers
- Rank in United States
- #53,330 of 1,627,098
- Works
- 738
- Citations
- 42k
- Citations per work
- 56.8
What does Vivian Andrew Fonseca research?
Vivian Andrew Fonseca's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences44660.5%
- Medicine44660.5%
- Everything else24433.0%
- Life Sciences486.5%
- 1Endocrinology, Diabetes and Metabolism39% of their works
- 2Cardiology and Cardiovascular Medicine8% of their works
- 3Surgery7% of their works
- 4Molecular Biology6% of their works
- 5Epidemiology4% of their works
- 6Physiology3% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Metabolism, Diabetes, and Cancer
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Pharmacology and Obesity Treatment
- Pancreatic function and diabetes
- Blood Pressure and Hypertension Studies
Which keywords describe Vivian Andrew Fonseca's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Disease, Diabetes, Clinical Guidelines, Cardiovascular Outcomes, Type 2 Diabetes and Obesity.
- Blood Pressure
- Weight Loss
- Pancreatic Islets
- Critical Care
- AMP-Activated Protein Kinase
- Metabolic Syndrome
- Hypoglycemia
- Obesity
- Cardiovascular Outcomes
- Diabetes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Disease
- Clinical Guidelines
- Type 2 Diabetes
- Continuous Glucose Monitoring
- Insulin Resistance
- Diabetes Mellitus
- Metformin
- Hyperglycemia
- Pharmacotherapy
- ß-Cell Dysfunction
- Hypertension
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Glycemic Control4873 topics
- Insulin Therapy4873 topics
- Cardiovascular Disease3713 topics
- Diabetes3272 topics
- Clinical Guidelines2992 topics
- Cardiovascular Outcomes2551 topic
- Type 2 Diabetes2551 topic
- Obesity1972 topics
- Continuous Glucose Monitoring1751 topic
- Hypoglycemia1751 topic
- Insulin Resistance1521 topic
- Metabolic Syndrome1521 topic
- Diabetes Mellitus1463 topics
- AMP-Activated Protein Kinase801 topic
- Metformin801 topic
- Critical Care571 topic
- Hyperglycemia571 topic
- Pancreatic Islets451 topic
- Pharmacotherapy451 topic
- Weight Loss451 topic
- ß-Cell Dysfunction451 topic
- Blood Pressure441 topic
- Hypertension441 topic
Where does Vivian Andrew Fonseca work?
Vivian Andrew Fonseca's main affiliation in the publication record is Tulane University, United States.
How many publications and citations does Vivian Andrew Fonseca have?
OpenAlex counts 738 works and 41,921 citations for Vivian Andrew Fonseca, an h-index of 104, ranking #141,024 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Vivian Andrew Fonseca. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.